IXPERIENCE Trademark

Trademark Overview

On Friday, June 27, 2014, a trademark application was filed for IXPERIENCE with the United States Patent and Trademark Office. The USPTO has given the IXPERIENCE trademark a serial number of 86322313. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, August 8, 2025. This trademark is owned by CNJ HOLDINGS, INC.. The IXPERIENCE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical consultation; patient assistance programs, namely, providing information to patients in the field of administering medications, patient counseling regarding hemophilia, counseling services relating to hemophilia management, providing patient information relating to the therapeutic properties of pharmaceuticals, and providing online information relating to therapeutic properties of pharmaceuticals; discount drug plan, namely, patient assistance programs to provide drugs at a discounted rate to low-income patients
ixperience

General Information

Serial Number86322313
Word MarkIXPERIENCE
Filing DateFriday, June 27, 2014
Status800 - REGISTERED AND RENEWED
Status DateFriday, August 8, 2025
Registration Number4923507
Registration DateTuesday, March 22, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements

Goods and ServicesMedical consultation; patient assistance programs, namely, providing information to patients in the field of administering medications, patient counseling regarding hemophilia, counseling services relating to hemophilia management, providing patient information relating to the therapeutic properties of pharmaceuticals, and providing online information relating to therapeutic properties of pharmaceuticals; discount drug plan, namely, patient assistance programs to provide drugs at a discounted rate to low-income patients

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 3, 2014
Primary Code044
First Use Anywhere DateFriday, June 5, 2015
First Use In Commerce DateFriday, June 5, 2015

Trademark Owner History

Party NameAPTEVO BIOTHERAPEUTICS LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSEATTLE, WA 98121
Party NameCNJ HOLDINGS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMANITOBA R3T5Y3
CA
Party NameCNJ HOLDINGS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMANITOBA R3T5Y3
CA
Party NameCNJ HOLDINGS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMANITOBA R3T5Y3
CA

Trademark Events

Event DateEvent Description
Tuesday, July 1, 2014NEW APPLICATION ENTERED
Wednesday, August 20, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 3, 2014PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, September 29, 2014ASSIGNED TO EXAMINER
Thursday, July 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 27, 2014ASSIGNED TO LIE
Tuesday, September 30, 2014NON-FINAL ACTION WRITTEN
Tuesday, September 30, 2014NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 24, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 23, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, March 23, 2015EXAMINERS AMENDMENT E-MAILED
Monday, March 23, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 23, 2015EXAMINER'S AMENDMENT ENTERED
Monday, March 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 9, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, February 16, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 17, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 22, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 9, 2015USE AMENDMENT FILED
Monday, January 25, 2016STATEMENT OF USE PROCESSING COMPLETE
Friday, January 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 11, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 11, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, May 13, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 16, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, July 12, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 11, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 11, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 11, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 11, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 11, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 22, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 15, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, March 24, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, August 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 8, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, August 8, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, August 8, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, March 22, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 14, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, August 12, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 12, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 12, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

ixperience patient providing information relating properties pharmaceuticals counseling therapeutic hemophilia namely